13 Similarly, in our previous report on sNfL in successive 5-year periods, 14 average sNfL levels showed an increasing trend starting in specimens obtained 5–10 years before clinical MS onset.
← all excerpts
Seroreactivity against lytic, latent and possible cross-reactive EBV antigens appears on average 10 years before MS induced preclinical neuroaxonal damage.
1
—
—